查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1762531

預灌封注射器填充及完工市場：產業趨勢及全球預測 - 依治療領域、注射器針筒材質、藥物分子、業務規模、重點地區

Prefilled Syringe Fill Finish Manufacturing Market: Industry Trends and Global Forecasts - Distribution by Type of Therapeutic Area, Type of Syringe Barrel Material, Type of Drug Molecule, Scale of Operation and Key Geographical Regions
出版日期: | 出版商: Roots Analysis | 英文 267 Pages | 商品交期: 最快1-2個工作天內

價格

預灌封注射器填充與完工市場：概覽

今年全球預灌封注射器填充和完工市場規模達 9.31億美元。預計在預測期內，該市場將以 11.9%的年複合成長率成長。

市場規模與機會分析依下列參數細分：

治療領域

  • 血液疾病
  • 傳染病
  • 代謝性疾病
  • 腫瘤疾病
  • 神經系統疾病
  • 自體免疫疾病
  • 其他

注射器針筒材質

  • 玻璃
  • 塑膠

針筒腔體數量

  • 單腔
  • 雙腔

藥物分子

  • 生物製劑
  • 小分子

業務尺寸

  • 商業化
  • 臨床前/臨床

主要地區

  • 北美
  • 歐洲
  • 亞太地區

預充式注射器填充製造市場：成長與趨勢

基本上，預充式注射器是包含預定劑量注射藥物的單劑量藥物。它們被用作注射藥物和疫苗的主要藥物容器。裝入預充式注射器的藥物種類包括血液刺激劑、紅血球生成素製劑、干擾素和治療性蛋白質。在過去十年中，隨著腸外給藥藥物的不斷發展，預充式注射器的使用量增加了三倍。值得注意的是，這些預充式注射器與傳統給藥系統（例如西林瓶和注射器）相比具有許多優勢，包括降低給藥錯誤的可能性、提高患者依從性以及降低微生物污染的風險。因此，預充式注射器是注射藥物輸送的首選，尤其是在治療慢性疾病（需要重複給藥）方面。

預充式注射器填充製造市場-IMG1

預充式注射器的眾多優勢，加上日益成長的自我用藥趨勢，促使許多藥物與此類裝置聯合使用獲得批准，導致對灌裝/灌裝業務外包的需求增加。此外，由於許多營運挑戰，例如需要密切監控和管理注射器填充量所需的技術專長，市場正見證著預先填充注射器填充和完工業務外包的趨勢。此外，目前對更安全、更便捷的給藥技術的需求，以及業界為降低成本和提高效率所做的努力，預計將在未來幾年推動預灌裝注射器灌裝和完工製造市場的成長。

預灌註注射器填充與完工市場：關鍵洞察

本報告深入探討了全球預先填充注射器填充和完工製造市場的現狀，並識別了行業內的潛在成長機會。報告的主要調查結果包括：

  • 全球有超過 100 家公司聲稱提供預先填充注射器合約填充和完工服務，其中近 50%的服務提供者是擁有 500 多名員工的大型公司。
  • 市場格局的特點是，該領域湧現出眾多知名公司，其中許多公司聲稱業務規模各異，且分佈在不同的地區。
  • 超過 55%的公司同時提供小分子藥物和生物製劑的填充服務，約20%的公司致力於生物製劑。
  • 不同規模和地區的公司紛紛加入，目的是提升整個供應鏈的競爭力，並滿足客戶不斷變化的需求。
預灌封注射器填充製造市場-IMG2
  • 多家合約服務供應商（約60家公司）提供臨床和商業規模的灌裝/完成服務，包括AMRI、Catalent Biologics、Pierre Fabrre和Sandoz。
  • 雖然大多數產業利害關係人位於已開發國家，但灌裝/完成業務印度、台灣和孟加拉等亞洲國家/地區興起。
  • 灌裝/完成服務提供者積極投資擴建項目，以升級其現有產能。
  • 如預期的那樣，大多數預灌封注射器灌裝/完成合約設施都屬於大型服務供應商，約佔全球可用設施的80%。
  • 對預充式注射器組合產品開發商的評估顯示，歐洲和北美是灌裝/封口服務提供者合作機會的關鍵地區。
  • 約有70種預充式注射器由大型公司生產，其中大多數公司聲稱能夠生產玻璃和塑膠材質的注射器針筒。
  • 短期至中期內，預計藥品開發商將灌裝/封口業務外包的情況將持續，合約服務市場的年成長率將超過11.9%。
  • 從長遠來看，預計預充式注射器填充/封口服務提供者的機會可能會在不同類型的針筒、業務規模和地理區域方面呈現高度多樣化。
預充式注射器填充製造市場-IMG3
  • 隨著預充式注射器需求的不斷成長以及對用戶友善型系統的關注，預計未來幾年市場機會將快速發展。

預充式注射器填充製造市場的參與者

  • Ajinomoto Bio-Pharma Services
  • AMRI
  • BioPharma Solutions
  • Emergent BioSolutions
  • Patheon（a Thermo Fisher Scientific Company）
  • Consort Medical
  • EVER Pharma
  • GlaxoSmithKline
  • IDT Biologika
  • Rentschler Biopharma
  • Siegfried
  • Vetter Pharma
  • Biocon
  • Intas Pharmaceuticals
  • Kemwell Biopharma
  • Square Pharmaceuticals.

目錄

第1章 簡介

第2章 執行摘要

第3章 簡介

  • 章節概述
  • 預灌封注射器簡介
  • 預灌封注射器的填充和完工過程
  • 預灌封注射器填充和完工市場的成長因素
  • 無菌注射劑填充和完工業務外包的需求
  • 灌裝和完工服務外包的優勢
  • 灌裝和完工業務外包的風險
  • 選擇灌裝和完工服務提供者時需要考慮的重要事項

第4章 市場市場格局

  • 章節概述
  • 預灌封注射器填充和完工服務提供者：市場格局

第5章 北美預灌封注射器灌裝和完工服務提供者：公司簡介

  • 章節概述
  • Ajinomoto Bio-Pharma Services
  • AMRI
  • BioPharma Solutions
  • Emergent BioSolutions
  • Patheon

第6章 歐洲預灌封注射器灌裝和完工服務提供者：公司簡介

  • 章節概述
  • Consort Medical
  • EVER Pharma
  • GlaxoSmithKline
  • IDT Biologika
  • Rentschler Biopharma
  • Siegfried
  • Vetter Pharma

第7章 亞太地區預灌封注射器填充和完工服務提供者：公司簡介

  • 章節概述
  • Biocon
  • Intas Pharmaceuticals
  • Kemwell Biopharma
  • Square Pharmaceuticals

第8章 預灌封注射器灌裝完工服務提供者：最新發展

  • 章節概述
  • 擴充列表
  • 合作模式
  • 合作與合作清單

第9章 產能分析

第10章 需求分析

第11章 供需地理評估

  • 章節概述
  • 假設和關鍵參數
  • 北美供需評估
  • 歐洲供需評估
  • 亞太地區供需評估

第12章 潛在夥伴分析

第13章 市場規模評估與機會分析

  • 章節概述
  • 預測研究方法與關鍵假設
  • 預灌封注射器填充服務市場（至2035）

第14章 未來成長機會

  • 章節概述
  • 不斷成長的注射劑藥物產品線
  • 預灌封注射器日益普及
  • 外包灌裝作業的偏好日益增加
  • 無菌填充技術的進步
  • 亞太地區的成長機會

第15章 案例研究：預灌封注射器製造商

  • 章節概述
  • 預充式注射器：現有/在研器械列表
  • 預充式注射器：製造商列表

第16章 結論

第17章 訪談紀錄

第18章 附錄1：表格資料

第19章 附錄2：公司列表

Product Code: RA100183

PREFILLED SYRINGE FILL FINISH MANUFACTURING MARKET: OVERVIEW

As per Roots Analysis, the global prefilled syringe fill finish manufacturing market valued at USD 931 million in the current year is anticipated to grow at a lucrative CAGR of 11.9% during the forecast period.

The market sizing and opportunity analysis has been segmented across the following parameters:

Type of Therapeutic Area

  • Blood Disorders
  • Infectious Diseases
  • Metabolic Disorders
  • Oncology Disorders
  • Neurological Disorders
  • Autoimmune Disorders
  • Others

Type of Syringe Barrel Material

  • Glass
  • Plastic

Number of Barrel Chambers

  • Single Chamber
  • Dual Chamber

Type of Drug Molecule

  • Biologic
  • Small Molecule

Scale of Operation

  • Commercial
  • Preclinical / Clinical

Key Geographical Regions

  • North America
  • Europe
  • Asia- Pacific

PREFILLED SYRINGE FILL FINISH MANUFACTURING MARKET: GROWTH AND TRENDS

Fundamentally, a prefilled syringe is a single dose of medication, containing a pre-measured amount of injectable. It is used as a primary drug container for injectable drugs and vaccines. Some of the categories of drugs packaged in prefilled syringes include blood stimulants, erythropoietin products, interferons and therapeutic proteins. Over the past ten years, with the increase in development of parenteral drugs, the usage of prefilled syringes has tripled. Notably, these prefilled syringes offer several advantages over traditional drug delivery systems (such as vials and syringes), including reduced chances of dosing errors, increased patient compliance and decreased risk of microbial contamination. As a result, prefilled syringes are preferably being used in the delivery of injectable drugs, especially in the treatment of chronic diseases (requiring repeated administration of the medications).

Prefilled Syringe Fill Finish Manufacturing Market - IMG1

The numerous benefits offered by prefilled syringes, coupled with the growing self-medication trend, have led to the approval of a number of drugs in combination with such devices, resulting in an increase in need to outsource fill / finish operations. Moreover, owing to a number of operational challenges, such as the requirement of technical expertise associated with close monitoring and control of syringe fill volume, the market has witnessed a shift in trend towards outsourcing of the fill / finish operations for prefilled syringes. Additionally, the current demand for safer, easier to use administration technologies along with the industry's efforts to reduce costs and increase efficiency are expected to drive the growth of the prefilled syringe fill finish manufacturing market in future.

PREFILLED SYRINGE FILL FINISH MANUFACTURING MARKET: KEY INSIGHTS

The report delves into the current state of the global prefilled syringe fill finish manufacturing market and identifies potential growth opportunities within industry. Some key findings from the report include:

  • Over 100 companies across the globe claim to provide contract fill / finish services for prefilled syringes; close to 50% of these service providers are large companies with over 500 employees.
  • The market landscape features the presence of well-established players in the domain, most of which claim to operate at various scales of operation and are located in different geographies.
  • Over 55% of the companies have the capabilities to offer fill / finish services for both small molecules and biologics; ~20% of the companies are offering these services for only biologics.
  • In order to acquire competencies across the supply chain and cater to the evolving needs of clients, companies offering services across different scales of operation have established presence in various geographies.
Prefilled Syringe Fill Finish Manufacturing Market - IMG2
  • Several contract service providers (~60), including AMRI, Catalent Biologics, Pierre Fabrre and Sandoz offer fill / finish services at both clinical and commercial scale of operation.
  • Although most industry stakeholders are based in the developed regions, fill / finish operations in Asian countries, such as India, Taiwan and Bangladesh, are emerging.
  • Fill / finish service providers are actively investing in expansion projects to upgrade existing capabilities and capacity; several partnerships, mostly focused on offering contract services, have also been forged.
  • As expected, majority of the installed contract fill / finish capacity for prefilled syringes belongs to the large service providers, accounting for around 80% of the available global capacity.
  • An evaluation of prefilled syringe combination product developers revealed that Europe and North America have emerged as the key regions for partnering opportunities for fill / finish service providers.
  • Around 70 prefilled syringes are being manufactured by large companies, most of which claim to be capable of fabricating syringe barrels from both glass and plastic materials.
  • We expect drug developers to continue to outsource their fill / finish operations in the short to midterm, resulting in an annualized growth at the rate of over 11.9% within the contract services market.
  • In the long-term, the projected opportunity for the fill / finish service providers for prefilled syringes is likely to be well distributed across various types of barrel chambers, scales of operation and geographical regions.
Prefilled Syringe Fill Finish Manufacturing Market - IMG3
  • With an increasing demand for prefilled syringes and focus on user-friendly systems, the market opportunity is projected to evolve at a rapid pace in the coming years.

Example Players in the Prefilled Syringe Fill Finish Manufacturing Market

  • Ajinomoto Bio-Pharma Services
  • AMRI
  • BioPharma Solutions
  • Emergent BioSolutions
  • Patheon (a Thermo Fisher Scientific Company)
  • Consort Medical
  • EVER Pharma
  • GlaxoSmithKline
  • IDT Biologika
  • Rentschler Biopharma
  • Siegfried
  • Vetter Pharma
  • Biocon
  • Intas Pharmaceuticals
  • Kemwell Biopharma
  • Square Pharmaceuticals.

PREFILLED SYRINGE FILL FINISH MANUFACTURING MARKET: RESEARCH COVERAGE

  • Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the prefilled syringe fill finish manufacturing market, focusing on key market segments, including [A] type of therapeutic area, [B] type of syringe barrel material, [C] number of barrel chambers, [D] type of drug molecule, [E] scale of operation and [F] key geographical regions.
  • Market Landscape: A comprehensive evaluation of companies offering contract fill / finish services for prefilled syringes, based on several relevant parameters, such as [A] year of establishment, [B] company size, [C] scale of operation, [D] location of the headquarters, [E] location of fill / finish facilities, [F] type of drug molecule, [G] syringe barrel material, [H] syringe fill volume and additional services offered and [I] installed capacity.
  • Company Profiles: In-depth profiles of the players engaged in this domain, focusing on [A] overview of the company, [B] financial information (if available), [C] service portfolio, [D] fill / finish facilities and [E] recent developments and an informed future outlook.
  • Recent Developments: A comprehensive competitive analysis of recent developments pertaining to contract fill / finish services, based on various parameters, such as [A] year of development, [B] type of activity / development, [C] scale of operation of the project, [D] location of expanded facility, [E] type of drug molecule involved and [F] additional services offered.
  • Capacity Analysis: An in-depth analysis of contract fill / finish capacity of prefilled syringes, examining factors, such as [A] company size of manufacturer, [B] scale of operation, [C] location of headquarters and fill / finish facilities and [D] type of drug molecule.
  • Demand Analysis: A detailed analysis of the current and future demand for fill / finish of prefilled syringes, based on various parameters, such as [A] marketed drugs available, [B] target patient population, [C] dosing frequency, [D] dose strength, [E] geography, [F] type of drug molecule, [G] therapeutic area, [H] syringe barrel material and [I] number of barrel chambers.
  • Geographical Assessment of Demand and Supply: An insightful geographical analysis of demand and supply, based on several parameters, such as [A] number of prefilled syringe combination product developers, [B] number of prefilled syringe manufacturers, [C] number of prefilled syringe fill / finish service providers, [D] number of prefilled syringe fill / finish facilities, and [E] capacity and demand for prefilled syringes in that particular geographical region.
  • Likely Partner Analysis: A detailed analysis of the potential strategic partners for prefilled syringe fill / finish service providers, based on various parameters, such as [A] developer strength, [B] pipeline strength, [C] type of drug molecule, [D] target therapeutic area and [E] location of the headquarters of the company.
  • Case Study 1: A detailed discussion on the potential areas of growth, such as [A] growing injectable drugs pipeline, [B] increasing popularity of prefilled syringes, [C] rise in preference for outsourcing of fill / finish operations, [D] technological advancements in aseptic fill / finish processes and [E] growing opportunities in the Asia-Pacific region.
  • Case Study 2: Elaborate assessment of prefilled syringe manufacturers landscape, based on a number of relevant parameters, such as [A] syringe barrel material, [B] number of barrel chambers, [C] type of needle system, [D] barrel volume, [E] year of establishment and [F] location of the headquarters of manufacturers.

KEY QUESTIONS ANSWERED IN THIS REPORT

  • How many companies are currently engaged in this market?
  • Which are the leading companies in this market?
  • What factors are likely to influence the evolution of this market?
  • What is the current and future market size?
  • What is the CAGR of this market?
  • How is the current and future market opportunity likely to be distributed across key market segments?

REASONS TO BUY THIS REPORT

  • The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
  • Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
  • The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

ADDITIONAL BENEFITS

  • Complimentary PPT Insights Packs
  • Complimentary Excel Data Packs for all Analytical Modules in the Report
  • 15% Free Content Customization
  • Detailed Report Walkthrough Session with Research Team
  • Free Updated report if the report is 6-12 months old or older

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Scope of the Report
  • 1.2. Research Methodology
    • 1.2.1. Research Assumptions
    • 1.2.2. Project Methodology
    • 1.2.3. Forecast Methodology
    • 1.2.4. Robust Quality Control
    • 1.2.5. Key Considerations
      • 1.2.5.1. Demographics
      • 1.2.5.2. Economic Factors
      • 1.2.5.3. Government Regulations
      • 1.2.5.4. Supply Chain
      • 1.2.5.5. COVID Impact / Related Factors
      • 1.2.5.6. Market Access
      • 1.2.5.7. Healthcare Policies
      • 1.2.5.8. Industry Consolidation
  • 1.3 Key Questions Answered
  • 1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

  • 3.1. Chapter Overview
  • 3.2. Introduction to Prefilled Syringes
    • 3.2.1. Classification of Prefilled Syringes
    • 3.2.2. Manufacturing of Prefilled Syringes
    • 3.2.3. Advantages of Prefilled Syringes
      • 3.2.3.1. Benefits to Healthcare Professionals and End Users
      • 3.2.3.2. Benefits to Manufacturers
  • 3.3. Fill / Finish Processing of Prefilled Syringes
    • 3.3.1. Steps Involved in Fill / Finish Process
    • 3.3.2. Methods of Filling and Stoppering of Prefilled Syringes
    • 3.3.3. Prefilled Syringe Filling Technologies
  • 3.4. Factors Contributing to the Growth of Prefilled Syringe Fill / Finish Market
  • 3.5. Need for Outsourcing Fill / Finish Operations of Sterile Injectables
  • 3.6. Advantages of Outsourcing Fill / Finish Services
  • 3.7. Risks Associated with Outsourcing of Fill / Finish Operations
  • 3.8. Key Considerations While Selecting a Fill / Finish Service Provider

4. MARKET LANDSCAPE

  • 4.1. Chapter Overview
  • 4.2. Prefilled Syringe Fill / Finish Service Providers: Overall Market Landscape
    • 4.2.1. Analysis by Year of Establishment
    • 4.2.2. Analysis by Company Size
    • 4.2.3. Analysis by Scale of Operation
    • 4.2.4. Analysis by Location of Headquarters
    • 4.2.5. Analysis by Location of Prefilled Syringe Fill / Finish Facilities
    • 4.2.6. Analysis by Type of Drug Molecule
    • 4.2.7. Analysis by Syringe Barrel Material
    • 4.2.8. Analysis by Syringe Fill Volume
    • 4.2.9. Analysis by Additional Services Offered
    • 4.2.10. Heat Map: Analysis by Company Size and Location of Headquarters
    • 4.2.11. Logo Landscape: Analysis by Company Size and Type of Drug Molecule
    • 4.2.12. Geographical Map: Analysis by Scale of Operation and Location of Fill / Finish Facilities
    • 4.2.13. Grid Representation: Distribution by Year of Establishment, Company Size and Type of Drug Molecule

5. PREFILLED SYRINGE FILL / FINISH SERVICE PROVIDERS IN NORTH AMERICA: COMPANY PROFILES

  • 5.1. Chapter Overview
  • 5.2. Ajinomoto Bio-Pharma Services
    • 5.2.1. Company Overview
    • 5.2.2. Recent Developments and Future Outlook
  • 5.3. AMRI
    • 5.3.1. Company Overview
    • 5.3.2. Recent Developments and Future Outlook
  • 5.4. BioPharma Solutions
    • 5.4.1. Company Overview
    • 5.4.2. Recent Developments and Future Outlook
  • 5.5. Emergent BioSolutions
    • 5.5.1. Company Overview
    • 5.5.2. Recent Developments and Future Outlook
  • 5.6. Patheon (a Thermo Fisher Scientific Company)
    • 5.6.1. Company Overview
    • 5.6.2. Recent Developments and Future Outlook

6. PREFILLED SYRINGE FILL / FINISH SERVICE PROVIDERS IN EUROPE: COMPANY PROFILES

  • 6.1. Chapter Overview
  • 6.2. Consort Medical
    • 6.2.1. Company Overview
    • 6.2.2. Recent Developments and Future Outlook
  • 6.3. EVER Pharma
    • 6.3.1. Company Overview
    • 6.3.2. Recent Developments and Future Outlook
  • 6.4. GlaxoSmithKline
    • 6.4.1. Company Overview
    • 6.4.2. Recent Developments and Future Outlook
  • 6.5. IDT Biologika
    • 6.5.1. Company Overview
    • 6.5.2. Recent Developments and Future Outlook
  • 6.6. Rentschler Biopharma
    • 6.6.1. Company Overview
    • 6.6.2. Recent Developments and Future Outlook
  • 6.7. Siegfried
    • 6.7.1. Company Overview
    • 6.7.2. Recent Developments and Future Outlook
  • 6.8. Vetter Pharma
    • 6.8.1. Company Overview
    • 6.8.2. Recent Developments and Future Outlook

7. PREFILLED SYRINGE FILL / FINISH SERVICE PROVIDERS IN ASIA-PACIFIC: COMPANY PROFILES

  • 7.1. Chapter Overview
  • 7.2. Biocon
    • 7.2.1. Company Overview
    • 7.2.2. Recent Developments and Future Outlook
  • 7.3. Intas Pharmaceuticals
    • 7.3.1. Company Overview
    • 7.3.2. Recent Developments and Future Outlook
  • 7.4. Kemwell Biopharma
    • 7.4.1. Company Overview
    • 7.4.2. Recent Developments and Future Outlook
  • 7.5. Square Pharmaceuticals
    • 7.5.1. Company Overview
    • 7.5.2. Recent Developments and Future Outlook

8. PREFILLED SYRINGE FILL / FINISH SERVICE PROVIDERS: RECENT DEVELOPMENTS

  • 8.1. Chapter Overview
  • 8.2. List of Expansions
    • 8.2.1. Analysis by Year of Expansion
    • 8.2.2. Analysis by Type of Expansion
    • 8.2.3. Analysis by Expanded Scale of Operation
    • 8.2.4. Analysis by Location of Expansion Project
    • 8.2.5. Analysis by Type of Drug Molecule Involved
    • 8.2.6. Analysis by Additional Services Offered (Expansion Specific)
  • 8.3. Partnership Models
  • 8.4. List of Partnerships and Collaborations
    • 8.4.1. Analysis by Year of Partnership
    • 8.4.2. Analysis by Type of Partnership
    • 8.4.3. Analysis by Scale of Operation (Deal Specific)
    • 8.4.4. Analysis by Additional Services Offered (Deal Specific)

9. CAPACITY ANALYSIS

  • 9.1. Chapter Overview
  • 9.2. Assumptions and Methodology
  • 9.3. Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units)
    • 9.3.1. Analysis by Company Size
    • 9.3.2. Analysis by Scale of Operation
    • 9.3.3. Analysis by Location of Headquarters
    • 9.3.4. Analysis by Location of Fill / Finish Facilities
    • 9.3.5. Analysis by Type of Drug Molecule
  • 9.4. Global, Prefilled Syringe Fill / Finish Capacity (by Volume)
    • 9.4.1. Analysis by Company Size (Manufacturer)
    • 9.4.2. Analysis by Scale of Operation
    • 9.4.3. Analysis by Location of Headquarters
    • 9.4.4. Analysis by Location of Fill / Finish Facilities
    • 9.4.5. Analysis by Type of Drug Molecule

10. DEMAND ANALYSIS

  • 10.1. Chapter Overview
  • 10.2. Assumptions and Methodology
  • 10.3. Global Demand for Prefilled Syringes Fill / Finish Services
    • 10.3.1. Global Demand for Commercialized Prefilled Syringes Fill / Finish Services
      • 10.3.1.1. Analysis by Geography
        • 10.3.1.1.1. North America
        • 10.3.1.1.2. Europe
        • 10.3.1.1.3. Asia-Pacific
        • 10.3.1.1.4. Latin America
        • 10.3.1.1.5. Middle East and Africa
      • 10.3.1.2. Analysis by Syringe Barrel Material
      • 10.3.1.3. Analysis by Number of Barrel Chambers
      • 10.3.1.4. Analysis by Type of Drug Molecule
      • 10.3.1.5. Analysis by Therapeutic Area
      • 10.3.1.6. Analysis by Specialty Syringes
    • 10.3.2. Global Demand for Clinical Prefilled Syringes Fill / Finish Services
  • 10.4. Demand and Supply Analysis
    • 10.4.1. Demand and Supply Analysis (Scenario 1)
    • 10.4.2. Demand and Supply Analysis (Scenario 2)
    • 10.4.3. Demand and Supply Analysis (Scenario 3)

11. GEOGRAPHICAL ASSESSMENT OF DEMAND AND SUPPLY

  • 11.1. Chapter Overview
  • 11.2. Assumptions and Key Parameters
  • 11.3. Demand and Supply Assessment in North America
    • 11.3.1. Key Geographies
      • 11.3.1.1. US
  • 11.4. Demand and Supply Assessment in Europe
    • 11.4.1. Key Geographies
      • 11.4.1.1. France
      • 11.4.1.2. Germany
      • 11.4.1.3. Italy
  • 11.5. Demand and Supply Assessment in Asia-Pacific Region
    • 11.5.1. Key Geographies
      • 11.5.1.1. India
      • 11.5.1.2. Japan

12. LIKELY PARTNER ANALYSIS

  • 12.1. Chapter Overview
  • 12.2. Methodology and Key Parameters
  • 12.3. Likely Partner Analysis
    • 12.3.1. Opportunities in North America
      • 12.3.1.1. Most Likely Partners for Prefilled Syringe Fill / Finish Service Providers
      • 12.3.1.2. Likely Partners for Prefilled Syringe Fill / Finish Service Providers
    • 12.3.2. Opportunities in Europe
      • 12.3.2.1. Most Likely Partners for Prefilled Syringe Fill / Finish Service Providers
      • 12.3.2.2. Likely Partners for Prefilled Syringe Fill / Finish Service Providers
    • 12.3.3. Opportunities in Asia-Pacific and Rest of the World
      • 12.3.3.1. Most Likely Partners for Prefilled Syringe Fill / Finish Service Providers
      • 12.3.3.2. Likely Partners for Prefilled Syringe Fill / Finish Service Providers

13. MARKET SIZING AND OPPORTUNITY ANALYSIS

  • 13.1. Chapter Overview
  • 13.2. Forecast Methodology and Key Assumptions
  • 13.3. Overall Prefilled Syringe Fill / Finish Services Market, Till 2035
    • 13.3.1. Prefilled Syringe Fill / Finish Services Market: Distribution by Scale of Operation, Till 2035
    • 13.3.2. Prefilled Syringe Fill / Finish Services Market: Distribution by Geographical Region
      • 13.3.2.1. Prefilled Syringe Fill / Finish Services Market in North America
      • 13.3.2.2. Prefilled Syringe Fill / Finish Services Market in Europe
      • 13.3.2.3. Prefilled Syringe Fill / Finish Services Market in Asia-Pacific
      • 13.3.2.4. Prefilled Syringe Fill / Finish Services Market Latin America
      • 13.3.2.5. Prefilled Syringe Fill / Finish Services Market in Middle East and Africa
    • 13.3.3. Prefilled Syringe Fill / Finish Services Market: Distribution by Type of Drug Molecule, Till 2035
    • 13.3.4. Prefilled Syringe Fill / Finish Services Market: Distribution by Therapeutic Area
    • 13.3.5. Prefilled Syringe Fill / Finish Services Market: Distribution by Syringe Barrel Material, Till 2035
    • 13.3.6. Prefilled Syringe Fill / Finish Services Market: Distribution by Number of Barrel Chambers, Till 2035

14. FUTURE GROWTH OPPORTUNITIES

  • 14.1. Chapter Overview
  • 14.2. Growing Injectable Drugs Pipeline
  • 14.3. Increase in Popularity of Prefilled Syringes
  • 14.4. Rise in Preference for Outsourcing Fill / Finish Activities
  • 14.5. Advances in Aseptic Fill / Finish Technologies
  • 14.6. Growing Opportunities in the Asia-Pacific Region

15. CASE STUDY: PREFILLED SYRINGE MANUFACTURERS

  • 15.1. Chapter Overview
  • 15.2. Prefilled Syringes: List of Available / Under Development Devices
    • 15.2.1. Analysis by Syringe Barrel Material
    • 15.2.2. Analysis by Number of Barrel Chambers
    • 15.2.3. Analysis by Type of Needle System
    • 15.2.4. Analysis by Barrel Volume
  • 15.3. Prefilled Syringes: List of Manufacturers
    • 15.3.1. Analysis by Year of Establishment
    • 15.3.2. Analysis by Location of Headquarters

16. CONCLUDING REMARKS

  • 16.1. Chapter Overview
  • 16.2. Key Takeaways

17. INTERVIEW TRANSCRIPTS

  • 17.1. Chapter Overview
  • 17.2. Company A
    • 17.2.1. Company Snapshot
    • 17.2.2. Interview Transcript: President and Cofounder
  • 17.3. Company B
    • 17.3.1. Company Snapshot
    • 17.3.2. Interview Transcript: Chief Technical Officer
  • 17.4. Company C
    • 17.4.1. Company Snapshot
    • 17.4.2. Interview Transcript: Chief Commercial Officer
  • 17.5. Company D
    • 17.5.1. Company Snapshot
    • 17.5.2. Interview Transcript: Associate Director, Head of Process Sciences Formulation and Fill / Finish
  • 17.6. Company E
    • 17.6.1. Company Snapshot
    • 17.6.2. Interview Transcript: Research Director and Head of Formulation Development
  • 17.7. Company F
    • 17.7.1. Company Snapshot
    • 17.7.2. Interview Transcript: Design Director

18. APPENDIX 1: TABULATED DATA

19. APPENDIX 2: LIST OF COMPANIES

List of Tables

  • Table 3.1 Classification of Prefilled Syringes
  • Table 4.1 Prefilled Syringe Fill / Finish Service Providers: List of Companies
  • Table 4.2 Prefilled Syringe Fill / Finish Service Providers: Information on Location of Fill / Finish Facilities
  • Table 4.3 Prefilled Syringe Fill / Finish Service Providers: Information on Type of Drug Molecule
  • Table 4.4 Prefilled Syringe Fill / Finish Service Providers: Information on Syringe Barrel Material
  • Table 4.5 Prefilled Syringe Fill / Finish Service Providers: Information on Syringe Fill Volume Range
  • Table 4.6 Prefilled Syringe Fill / Finish Service Providers: Information on Additional Services Offered
  • Table 4.7 Prefilled Syringe Fill / Finish Service Providers: Distribution by Company Size and Location of Headquarters
  • Table 4.8 Prefilled Syringe Fill / Finish Service Providers: Information on Fill / Finish Capability
  • Table 5.1 Prefilled Syringes Fill / Finish Service Providers in North America: List of Profiled Companies
  • Table 5.2 Ajinomoto Bio-Pharma Services: Company Snapshot
  • Table 5.3 Ajinomoto Bio-Pharma Services: Recent Developments and Future Outlook
  • Table 5.4 AMRI: Company Snapshot
  • Table 5.5 AMRI: Recent Developments and Future Outlook
  • Table 5.6 BioPharma Solutions: Company Snapshot
  • Table 5.7 BioPharma Solutions: Recent Developments and Future Outlook
  • Table 5.8 Emergent BioSolutions: Company Snapshot
  • Table 5.9 Emergent BioSolutions: Recent Developments and Future Outlook
  • Table 5.10 Patheon: Company Snapshot
  • Table 5.11 Patheon: Recent Developments and Future Outlook
  • Table 6.1 Prefilled Syringe Fill / Finish Service Providers in Europe: List of Profiled Companies
  • Table 6.2 Consort Medical: Company Snapshot
  • Table 6.3 Consort Medical: Recent Developments and Future Outlook
  • Table 6.4 EVER Pharma: Company Snapshot
  • Table 6.5 EVER Pharma: Recent Developments and Future Outlook
  • Table 6.6 GlaxoSmithKline: Company Snapshot
  • Table 6.7 GlaxoSmithKline: Recent Developments and Future Outlook
  • Table 6.8 IDT Biologika: Company Snapshot
  • Table 6.9 IDT Biologika: Recent Developments and Future Outlook
  • Table 6.10 Rentschler Biopharma: Company Snapshot
  • Table 6.11 Rentschler Biopharma: Recent Developments and Future Outlook
  • Table 6.12 Siegfried: Company Snapshot
  • Table 6.13 Siegfried: Recent Developments and Future Outlook
  • Table 6.14 Vetter Pharma: Company Snapshot
  • Table 6.15 Vetter Pharma: Recent Developments and Future Outlook
  • Table 7.1 Prefilled Syringes Fill / Finish Service Providers in Asia-Pacific: List of Profiled Companies
  • Table 7.2 Biocon: Company Snapshot
  • Table 7.3 Biocon: Recent Developments and Future Outlook
  • Table 7.4 Intas Pharmaceuticals: Company Snapshot
  • Table 7.5 Intas Pharmaceuticals: Recent Developments and Future Outlook
  • Table 7.6 Kemwell Biopharma: Company Snapshot
  • Table 7.7 Kemwell Biopharma: Recent Developments and Future Outlook
  • Table 7.8 Square Pharmaceuticals: Company Snapshot
  • Table 7.9 Square Pharmaceuticals: Recent Developments and Future Outlook
  • Table 8.1 Prefilled Syringe Fill / Finish Service Providers: Recent Expansions, Since 2015
  • Table 8.2 Expansions: Information on Additional Services Offered
  • Table 8.3 Prefilled Syringe Fill / Finish Service Providers: Partnerships and Collaborations, Since 2015
  • Table 8.4 Partnerships: Information on Type of Services
  • Table 9.1 Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units): Average Capacity by Company Size (Sample Data Set)
  • Table 10.1 Global Prefilled Syringe Fill / Finish Services Annual Supply, Till 2035 (Million Units)
  • Table 10.2 Global Annual Outsourcing Demand for Prefilled Syringe Fill / Finish Services (Million Units)
  • Table 10.3 Global Annual Outsourcing Demand for Prefilled Syringe Fill / Finish Services (Million Units)
  • Table 10.4 Global Annual Outsourcing Demand for Prefilled Syringe Fill / Finish Services (Million Units)
  • Table 11.1 Demand and Supply Assessment: North America
  • Table 11.2 Demand and Supply Assessment: Europe
  • Table 11.3 Demand and Supply Assessment: Asia-Pacific
  • Table 12.1 Opportunities in North America: Most Likely Partners for Prefilled Syringe Fill / Finish Service Providers
  • Table 12.2 Opportunities in North America: Likely Partners for Prefilled Syringe Fill / Finish Service Providers
  • Table 12.3 Opportunities in Europe: Most Likely Partners for Prefilled Syringe Fill / Finish Service Providers
  • Table 12.4 Opportunities in Europe: Likely Partners for Prefilled Syringe Fill / Finish Service Providers
  • Table 12.5 Opportunities in Asia-Pacific and Rest of the World: Most Likely Partners for Prefilled Syringe Fill / Finish Service Providers
  • Table 12.6 Opportunities in Asia-Pacific and Rest of the World: Likely Partners for Prefilled Syringe Fill / Finish Service Providers
  • Table 14.1 List of Pharmaceutical Robotics Manufacturers
  • Table 14.2 List of Companies Supplying Ready-to-Use Packaging Components
  • Table 14.3 Patent Expiry of Biologics, Since 2018
  • Table 15.1 Prefilled Syringes: List of Available / Under Development Devices
  • Table 15.2 Prefilled Syringes: List of Manufacturers
  • Table 16.1 Prefilled Syringe Fill / Finish Services Market: Key Takeaways
  • Table 17.1 Bio Elpida: Key Highlights
  • Table 17.2 Intas Pharmaceuticals: Key Highlights
  • Table 17.3 IDT Biologika: Key Highlights
  • Table 17.4 Takeda: Key Highlights
  • Table 17.5 Syngene: Key Highlights
  • Table 17.6 IDEO: Key Highlights
  • Table 18.1 Prefilled Syringe Fill / Finish Service Providers: Distribution by Year of Establishment
  • Table 18.2 Prefilled Syringe Fill / Finish Service Providers: Distribution by Company Size
  • Table 18.3 Prefilled Syringe Fill / Finish Service Providers: Distribution by Scale of Operation
  • Table 18.4 Prefilled Syringe Fill / Finish Service Providers: Distribution by Location of Headquarters
  • Table 18.5 Prefilled Syringe Fill / Finish Service Providers: Distribution by Location of Fill / Finish Facilities
  • Table 18.6 Prefilled Syringe Fill / Finish Service Providers: Distribution by Company Size and Type of Drug Molecule
  • Table 18.7 Prefilled Syringe Fill / Finish Service Providers: Distribution by Syringe Barrel Material
  • Table 18.8 Prefilled Syringe Fill / Finish Service Providers: Distribution by Syringe Fill Volume
  • Table 18.9 Prefilled Syringe Fill / Finish Service Providers: Distribution by Additional Services Offered
  • Table 18.10 Partnerships and Collaborations: Distribution by Year of Partnership, Since 2015
  • Table 18.11 Partnerships and Collaborations: Distribution by Type of Partnership
  • Table 18.12 Partnerships and Collaborations: Distribution by Scale of Operation (Deal Specific)
  • Table 18.13 Partnerships and Collaborations: Distribution by Additional Services Offered (Deal Specific)
  • Table 18.14 Most Active Players: Distribution by Number of Partnerships
  • Table 18.15 Expansions: Distribution by Year of Expansion, Since 2015
  • Table 18.16 Expansions: Distribution by Type of Expansion
  • Table 18.17 Expansions: Distribution by Expanded Scale of Operation
  • Table 18.18 Expansions: Distribution by Location of Expansion Project
  • Table 18.19 Expansions: Distribution by Type of Drug Molecule Involved
  • Table 18.20 Expansions: Distribution by Additional Services Offered (Expansion Specific)
  • Table 18.21 Global, Prefilled Syringe Fill / Finish Capacity: Distribution of Capacity by Size of Manufacturer (Sample Data Set)
  • Table 18.22 Global, Prefilled Syringe Fill / Finish Capacity: Distribution by Company Size of Manufacturer (in Million Units)
  • Table 18.23 Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units): Distribution by Scale of Operation (in Million Units)
  • Table 18.24 Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units): Distribution by Location of Headquarters (in Million Units)
  • Table 18.25 Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units): Distribution by Location of Fill / Finish Facilities (in Million Units)
  • Table 18.26 Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units): Distribution by Type of Drug Molecule (in Million Units)
  • Table 18.27 Global, Prefilled Syringe Fill / Finish Capacity: Distribution by Company Size of Manufacturer (in Million Liters)
  • Table 18.28 Global, Prefilled Syringe Fill / Finish Capacity (by Volume): Distribution by Scale of Operation (in Million Liters)
  • Table 18.29 Global, Prefilled Syringe Fill / Finish Capacity (by Volume): Distribution by Location of Headquarters (in Million Liters)
  • Table 18.30 Global, Prefilled Syringe Fill / Finish Capacity (by Volume): Distribution by Location of Fill / Finish Facilities (in Million Liters)
  • Table 18.31 Global, Prefilled Syringe Fill / Finish Capacity (by Volume): Distribution by Type of Drug Molecule (in Million Liters)
  • Table 18.32 Global, Demand for Prefilled Syringe Fill / Finish Services
  • Table 18.33 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Geography
  • Table 18.34 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Type of Drug Molecule
  • Table 18.35 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Therapeutic Area
  • Table 18.36 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Syringe Barrel Material
  • Table 18.37 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Number of Barrel Chambers
  • Table 18.38 Demand and Supply Assessment: North America
  • Table 18.39 Demand and Supply Assessment: Europe
  • Table 18.40 Demand and Supply Assessment: Asia-Pacific and Rest of the World
  • Table 18.41 Likely Partner Analysis: Distribution by Geography
  • Table 18.42 Overall Prefilled Syringe Fill / Finish Services Market, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Billion)
  • Table 18.43 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Scale of Operation, Conservative, Base and Optimistic Scenarios, (USD Million)
  • Table 18.44 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Geographical Location, Conservative, Base and Optimistic Scenarios, (USD Million)
  • Table 18.45 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Type of Drug Molecule, Conservative, Base and Optimistic Scenarios, (USD Million)
  • Table 18.46 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Therapeutic Area, Conservative, Base and Optimistic Scenarios, (USD Million)
  • Table 18.47 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Syringe Barrel Material, Conservative, Base and Optimistic Scenarios, (USD Million)
  • Table 18.48 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Number of Barrel Chambers, Conservative, Base and Optimistic Scenarios, (USD Million)
  • Table 18.49 Prefilled Syringes: Distribution by Syringe Barrel Material
  • Table 18.50 Prefilled Syringes: Distribution by Number of Barrel Chambers
  • Table 18.51 Prefilled Syringes: Distribution by Type of Needle System
  • Table 18.52 Prefilled Syringes: Distribution by Barrel Volume
  • Table 18.53 Prefilled Syringe Manufacturers: Distribution by Year of Establishment
  • Table 18.54 Prefilled Syringe Manufacturers: Distribution by Company Size
  • Table 18.55 Prefilled Syringe Manufacturers: Distribution by Location of Headquarters

List of Figures

  • Figure 3.1 Prefilled Syringe Manufacturing: Common Processes
  • Figure 3.2 Prefilled Syringes: Fill / Finish Process
  • Figure 3.3 Risks and Challenges of Outsourcing Fill / Finish Operations
  • Figure 3.4 Key Considerations while Selecting a Fill / Finish Service Provider
  • Figure 4.1 Prefilled Syringe Fill / Finish Service Providers: Distribution by Year of Establishment
  • Figure 4.2 Prefilled Syringe Fill / Finish Service Providers: Distribution by Company Size
  • Figure 4.3 Prefilled Syringe Fill / Finish Service Providers: Distribution by Scale of Operation
  • Figure 4.4 Prefilled Syringe Fill / Finish Service Providers: Distribution by Location of Headquarters
  • Figure 4.5 Prefilled Syringe Fill / Finish Service Providers: Distribution by Location of Prefilled Syringe Fill / Finish Facilities
  • Figure 4.6 Prefilled Syringe Fill / Finish Service Providers: Distribution by Type of Drug Molecule
  • Figure 4.7 Prefilled Syringe Fill / Finish Service Providers: Distribution by Syringe Barrel Material
  • Figure 4.8 Prefilled Syringe Fill / Finish Service Providers: Distribution by Syringe Fill Volume
  • Figure 4.9 Prefilled Syringe Fill / Finish Service Providers: Distribution by Additional Services Offered
  • Figure 4.10 Prefilled Syringe Fill / Finish Service Providers: Distribution by Company Size and Type of Drug Molecule
  • Figure 4.11 Prefilled Syringe Fill / Finish Service Providers: Distribution by Scale of Operation and Location of Fill / Finish Facilities
  • Figure 4.12 Prefilled Syringe Fill / Finish Service Providers: Distribution by Year of Establishment, Company Size and Type of Drug Molecule
  • Figure 8.1 Expansions: Distribution by Year of Expansion, Since 2015
  • Figure 8.2 Expansions: Distribution by Type of Expansion
  • Figure 8.3 Expansions: Distribution by Expanded Scale of Operation
  • Figure 8.4 Expansions: Distribution by Location of Expansion Project
  • Figure 8.5 Expansions: Distribution by Type of Drug Molecule Involved
  • Figure 8.6 Expansions: Distribution by Additional Services Offered (Expansion Specific)
  • Figure 8.7 Partnerships and Collaborations: Cumulative Trend by Year, Since 2015
  • Figure 8.8 Partnerships and Collaborations: Distribution by Type of Partnership
  • Figure 8.9 Partnerships and Collaborations: Distribution by Scale of Operation (Deal Specific)
  • Figure 8.10 Partnerships and Collaborations: Distribution by Additional Services Offered (Deal Specific)
  • Figure 9.1 Global, Prefilled Syringe Fill / Finish Capacity: Distribution of Capacity by Company Size (Sample Data Set)
  • Figure 9.2 Global, Prefilled Syringe Fill / Finish Capacity: Distribution by Company Size (in Million Units)
  • Figure 9.3 Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units): Distribution by Scale of Operation (in Million Units)
  • Figure 9.4 Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units): Distribution by Location of Headquarters (in Million Units)
  • Figure 9.5 Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units): Distribution by Location of Fill / Finish Facilities (in Million Units)
  • Figure 9.6 Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units): Distribution by Type of Drug Molecule (in Million Units)
  • Figure 9.7 Global, Prefilled Syringe Fill / Finish Capacity: Distribution by Company Size (in Million Liters)
  • Figure 9.8 Global, Prefilled Syringe Fill / Finish Capacity (by Volume): Distribution by Scale of Operation (in Million Liters)
  • Figure 9.9 Global, Prefilled Syringe Fill / Finish Capacity (by Volume): Distribution by Location of Headquarters (in Million Liters)
  • Figure 9.10 Global, Prefilled Syringe Fill / Finish Capacity (by Volume): Distribution by Location of Fill / Finish Facilities (in Million Liters)
  • Figure 9.11 Global, Prefilled Syringe Fill / Finish Capacity (by Volume): Distribution by Type of Drug Molecule (in Million Liters)
  • Figure 10.1 Global, Demand for Prefilled Syringe Fill / Finish Services
  • Figure 10.2 Global, Demand for Commercialized Prefilled Syringe Fill / Finish Services
  • Figure 10.3 Global, Demand for Prefilled Syringe Fill / Finish Services: Share of North America
  • Figure 10.4 Global, Demand for Prefilled Syringe Fill / Finish Services: Share of Europe
  • Figure 10.5 Global, Demand for Prefilled Syringe Fill / Finish Services: Share of Asia-Pacific
  • Figure 10.6 Global, Demand for Prefilled Syringe Fill / Finish Services: Share of Latin America
  • Figure 10.7 Global, Demand for Prefilled Syringe Fill / Finish Services: Share of Middle East and Africa
  • Figure 10.8 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Syringe Barrel Material
  • Figure 10.9 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Number of Barrel Chambers
  • Figure 10.10 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Type of Drug Molecule
  • Figure 10.11 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Therapeutic Area
  • Figure 10.12 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Specialty Syringes
  • Figure 10.13 Global, Demand for Clinical Prefilled Syringe Fill / Finish Services
  • Figure 10.14 Global, Prefilled Syringe Fill / Finish Services: Demand and Supply Dynamics (Scenario 1)
  • Figure 10.15 Global, Prefilled Syringe Fill / Finish Services: Demand and Supply Dynamics (Scenario 2)
  • Figure 10.16 Global, Prefilled Syringe Fill / Finish Services: Demand and Supply Dynamics (Scenario 3)
  • Figure 11.1 Demand and Supply Assessment: North America
  • Figure 11.2 Demand and Supply Assessment: US
  • Figure 11.3 Demand and Supply Assessment: Europe
  • Figure 11.4 Demand and Supply Assessment: France
  • Figure 11.5 Demand and Supply Assessment: Germany
  • Figure 11.6 Demand and Supply Assessment: Italy
  • Figure 11.7 Demand and Supply Assessment: Asia-Pacific Region
  • Figure 11.8 Demand and Supply Assessment: India
  • Figure 11.9 Demand and Supply Assessment: Japan
  • Figure 12.1 Likely Partner Analysis: Distribution by Company Size and Location of Headquarters
  • Figure 13.1 Overall Prefilled Syringe Fill / Finish Services Market, Till 2035 (USD Billion)
  • Figure 13.2 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Scale of Operation (USD Million)
  • Figure 13.3 Prefilled Syringe Fill / Finish Services Market: Distribution by Geographical Location (USD Million)
  • Figure 13.4 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Geographical Location, North America (USD Million)
  • Figure 13.5 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Geographical Location, Europe (USD Million)
  • Figure 13.6 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Geographical Location, Asia-Pacific (USD Million)
  • Figure 13.7 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Geographical Location, Latin America (USD Million)
  • Figure 13.8 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Geographical Location, Middle East and Africa (USD Million)
  • Figure 13.9 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Type of Drug Molecule (USD Million)
  • Figure 13.10 Prefilled Syringe Fill / Finish Services Market: Distribution by Therapeutic Area (USD Million)
  • Figure 13.11 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Syringe Barrel Material (USD Million)
  • Figure 13.12 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Number of Barrel Chambers (USD Million)
  • Figure 14.1 Growth Opportunities for Prefilled Syringe Fill / Finish Service Providers
  • Figure 14.2 Pipeline Distribution by Route of Administration
  • Figure 14.3 FDA Approved Biologics and Biosimilars, Since 2014
  • Figure 14.4 Approved Prefilled Syringe Combination Products: Cumulative Distribution by Approval Year
  • Figure 14.5 Clinical Stage Prefilled Syringes Combination Products: Distribution by Phase of Development
  • Figure 15.1 Prefilled Syringes: Distribution by Syringe Barrel Material
  • Figure 15.2 Prefilled Syringes: Distribution by Number of Barrel Chambers
  • Figure 15.3 Prefilled Syringes: Distribution by Type of Needle System
  • Figure 15.4 Prefilled Syringes: Distribution by Barrel Volume
  • Figure 15.5 Prefilled Syringe Developers: Distribution by Year of Establishment
  • Figure 15.6 Prefilled Syringe Developers: Distribution by Location of Headquarters